Literature DB >> 25258301

A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.

Tomasz Stokowy1, Bartosz Wojtaś2, Jolanta Krajewska3, Ewa Stobiecka3, Henning Dralle4, Thomas Musholt5, Steffen Hauptmann6, Dariusz Lange7, László Hegedüs8, Barbara Jarząb3, Knut Krohn9, Ralf Paschke10, Markus Eszlinger11.   

Abstract

The inherent diagnostic limitations of thyroid fine needle aspiration (FNA), especially in the "indeterminate" category, can be partially overcome by molecular analyses. We aimed at the identification of miRNAs that could be used to improve the discrimination of indeterminate FNAs. miRNA expression profiling was performed for 17 follicular carcinomas (FTCs) and 8 follicular adenomas (FAs). The microarray results underwent cross-comparison using three additional microarray data sets. Candidate miRNAs were validated by qPCR in an independent set of 32 FTCs and 46 FAs. Sixty-eight differentially expressed miRNAs were identified. Thirteen miRNAs could be confirmed by cross comparison. A two-miRNA-classifier was established improving the diagnostic applicability and resulted in a sensitivity of 82% and a specificity of 49%. We present a classifier that has the potential to be successfully evaluated in cytology material for its capability to discriminate (mutation negative) indeterminate cytologies and thereby improving the pre-surgical diagnostics of thyroid nodules.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Classifier; Follicular thyroid adenoma; Follicular thyroid cancer

Mesh:

Substances:

Year:  2014        PMID: 25258301     DOI: 10.1016/j.mce.2014.09.017

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

Review 1.  Molecular profiling of thyroid nodule fine-needle aspiration cytology.

Authors:  Markus Eszlinger; Lorraine Lau; Sana Ghaznavi; Christopher Symonds; Shamir P Chandarana; Moosa Khalil; Ralf Paschke
Journal:  Nat Rev Endocrinol       Date:  2017-03-31       Impact factor: 43.330

2.  Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.

Authors:  Tomasz Stokowy; Bartosz Wojtas; Barbara Jarzab; Knut Krohn; David Fredman; Henning Dralle; Thomas Musholt; Steffen Hauptmann; Dariusz Lange; László Hegedüs; Ralf Paschke; Markus Eszlinger
Journal:  Endocrine       Date:  2016-07-29       Impact factor: 3.633

3.  Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.

Authors:  Emmanuel Labourier; Alexander Shifrin; Anne E Busseniers; Mark A Lupo; Monique L Manganelli; Bernard Andruss; Dennis Wylie; Sylvie Beaudenon-Huibregtse
Journal:  J Clin Endocrinol Metab       Date:  2015-05-12       Impact factor: 5.958

4.  Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15.

Authors:  Feng-Jiao Huang; Xiao-Yi Zhou; Lei Ye; Xiao-Chun Fei; Shu Wang; Weiqing Wang; Guang Ning
Journal:  BMC Cancer       Date:  2016-02-15       Impact factor: 4.430

5.  Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations.

Authors:  Dennis Wylie; Sylvie Beaudenon-Huibregtse; Brian C Haynes; Thomas J Giordano; Emmanuel Labourier
Journal:  J Pathol Clin Res       Date:  2016-02-08

6.  Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution.

Authors:  Geneviève Dom; Sandra Frank; Sebastien Floor; Pashalina Kehagias; Frederick Libert; Catherine Hoang; Guy Andry; Alex Spinette; Ligia Craciun; Nicolas de Saint Aubin; Christophe Tresallet; Frederique Tissier; Frederique Savagner; Samira Majjaj; Ilse Gutierrez-Roelens; Etienne Marbaix; Jacques E Dumont; Carine Maenhaut
Journal:  Oncotarget       Date:  2017-12-08

Review 7.  Personalized treatment options for thyroid cancer: current perspectives.

Authors:  Fatemeh Khatami; Bagher Larijani; Shekoufeh Nikfar; Mandana Hasanzad; Kiarad Fendereski; Seyed Mohammad Tavangar
Journal:  Pharmgenomics Pers Med       Date:  2019-09-13

8.  Reciprocal Dysregulation of MiR-146b and MiR-451 Contributes in Malignant Phenotype of Follicular Thyroid Tumor.

Authors:  Margarita Knyazeva; Ekaterina Korobkina; Alexey Karizky; Maxim Sorokin; Anton Buzdin; Sergey Vorobyev; Anastasia Malek
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

9.  Integrated microRNA-mRNA analyses of distinct expression profiles in follicular thyroid tumors.

Authors:  Jiadong Chi; Xiangqian Zheng; Ming Gao; Jingzhu Zhao; Dapeng Li; Jiansen Li; Li Dong; Xianhui Ruan
Journal:  Oncol Lett       Date:  2017-10-06       Impact factor: 2.967

10.  Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears.

Authors:  Sergei E Titov; Mikhail K Ivanov; Pavel S Demenkov; Gevork A Katanyan; Eugenia S Kozorezova; Anastasia V Malek; Yulia A Veryaskina; Igor F Zhimulev
Journal:  BMC Cancer       Date:  2019-10-28       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.